| Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | ||
|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||
Net loss | ||||||
-48,590 | -30,138 | -50,049 | - | - | ||
Net income | ||||||
- | - | - | 25,313 | 17,519 | ||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||||
Depreciation of property and equipment | ||||||
2,060 | 1,853 | 1,576 | 1,395 | 1,296 | ||
Amortization of intangible assets | ||||||
4,012 | 986 | 210 | 263 | 109 | ||
Deferred tax (benefit) expense | ||||||
62 | -71 | 6,187 | -3,857 | -16,045 | ||
Share-based compensation | ||||||
14,008 | 23,526 | 24,488 | 14,493 | - | ||
Share-based compensation | ||||||
- | - | - | - | 1,249 | ||
Losses on disposal of property and equipment | ||||||
-26 | -2 | -35 | 0 | -86 | ||
Impairment loss on long-term investments | ||||||
4,424 | - | - | - | - | ||
Impairment loss on equity investment | ||||||
- | 495 | 772 | - | - | ||
Provision for bad debt | ||||||
231 | 29 | 3,064 | - | - | ||
Write-off of deferred offering expenses | ||||||
- | 0 | 0 | 522 | - | ||
Interest expense relating to convertible note | ||||||
- | - | 0 | 0 | 650 | ||
Changes in fair value of the derivative component of the convertible note | ||||||
- | - | 0 | 0 | -4,429 | ||
Changes in fair value of the structured deposit | ||||||
0 | 0 | 174 | -181 | - | ||
Loss from equity method investments | ||||||
-327 | -58 | -63 | - | - | ||
Reimbursement of American Depositary Receipt (ADR) program related expenses | ||||||
0 | 200 | 0 | 427 | - | ||
Gain on disposal of subsidiaries | ||||||
842 | 19,720 | - | - | - | ||
Accumulated deficit brought forward from acquired VIE | ||||||
357 | 0 | 15 | - | - | ||
Changes in operating assets and liabilities: | ||||||
Account payable | ||||||
0 | 3 | - | - | - | ||
Accounts receivable | ||||||
0 | 628 | -7,883 | 1,922 | 6,539 | ||
Accounts receivable due from employees | ||||||
- | - | 0 | 0 | -37 | ||
Prepayments and other current assets | ||||||
4,950 | 626 | -21,251 | 6,852 | 4,232 | ||
Deposits | ||||||
-7 | 685 | -1,367 | 666 | - | ||
Accrued expenses and other current liabilities | ||||||
1,785 | 7,972 | -6,656 | 6,097 | - | ||
Deposits | ||||||
- | - | - | - | -79 | ||
Accrued expenses and other current liabilities | ||||||
- | - | - | - | 3,778 | ||
Accrued payroll and welfare payable | ||||||
63 | 260 | -2,454 | 2,840 | 430 | ||
Amount due to a related party | ||||||
- | - | 0 | 0 | -1,407 | ||
Long-term payables | ||||||
-3,016 | -354 | 422 | 2,237 | 3,050 | ||
Income tax payable | ||||||
-328 | 769 | -1,428 | 764 | 488 | ||
Net cash provided by (used in) operating activities | ||||||
-31,078 | - | - | - | - | ||
Net cash generated from (used in) operating activities | ||||||
- | -16,469 | 6,542 | 40,381 | 4,819 | ||
Cash flows from investing activities | ||||||
Acquisition of property and equipment | ||||||
11,203 | 3,873 | 1,577 | 2,493 | 1,505 | ||
Acquisition of intangible assets | ||||||
329 | 0 | 137 | 277 | 69 | ||
Cash received from disposal of subsidiary | ||||||
11,038 | 32,319 | - | - | - | ||
Acquisition of other non-current assets | ||||||
46,465 | 4,088 | 9,029 | 3,886 | 452 | ||
Restricted cash | ||||||
0 | -993 | -320 | -400 | 651 | ||
Cash paid for business combination, net of cash | ||||||
57,535 | 960 | 14,388 | - | - | ||
Cash paid for short-term investments | ||||||
3,074 | 30,745 | 6,857 | - | - | ||
Cash paid for time deposits | ||||||
0 | 135,234 | 320,773 | - | - | ||
Cash received from return of time deposits | ||||||
123,679 | 199,749 | 199,249 | - | - | ||
Cash received from return of short-term investments | ||||||
0 | 14,403 | 10,834 | - | - | ||
Short-term investments | ||||||
- | - | - | 11,492 | - | ||
Time deposits | ||||||
- | - | - | -46,035 | - | ||
Time deposits | ||||||
- | - | - | - | -20,002 | ||
Change in amounts due from related parties | ||||||
- | - | 0 | 0 | -31,094 | ||
Proceeds from disposal of property and equipment | ||||||
543 | 3 | 15 | 1 | 168 | ||
Net cash (used in) provided by investing activities | ||||||
16,654 | - | - | - | - | ||
Net cash (used in) generated from investing activities | ||||||
- | 72,567 | -142,343 | -63,782 | 8,583 | ||
Cash flows from financing activities | ||||||
Proceeds from short-term bank borrowings | ||||||
0 | 0 | 26,861 | 161 | 33,251 | ||
Repayment of short-term bank borrowings | ||||||
0 | 0 | 26,861 | 2,224 | 31,136 | ||
Cash received from release of restricted cash | ||||||
379 | 0 | 29,460 | 9,108 | -9,335 | ||
Cash paid for restricted cash | ||||||
0 | 0 | -29,460 | - | - | ||
Proceeds from the issuance of the convertible note | ||||||
- | - | - | 0 | 20,249 | ||
Proceeds from the exercise of share options | ||||||
858 | 1,809 | 2,798 | 7,863 | 539 | ||
Proceeds from the private placement | ||||||
0 | 0 | 114,099 | 0 | 15,196 | ||
Proceeds from the issuance of ordinary shares | ||||||
- | - | - | 0 | - | ||
Proceeds from the initial public offering ("IPO"), net of issuance costs | ||||||
- | - | 0 | 0 | 75,464 | ||
Repurchase of ordinary shares | ||||||
2,656 | 18,874 | 1,354 | 0 | - | ||
Payment of dividends | ||||||
- | - | 0 | 0 | 32,133 | ||
Reimbursement of ADR program related expenses | ||||||
0 | 200 | 0 | 509 | - | ||
Net cash provided by (used in) financing activities | ||||||
-1,419 | - | - | - | - | ||
Payment for public offering expenses | ||||||
- | 0 | 0 | 1,730 | - | ||
Net cash generated from financing activities | ||||||
- | -16,865 | 115,543 | 13,687 | 72,095 | ||
Effect of exchange rate changes on cash and cash equivalents | ||||||
-6,286 | 7 | 7,152 | 243 | -795 | ||
Net (decrease) increase in cash and cash equivalents | ||||||
-22,129 | 39,240 | -13,106 | -9,471 | 84,702 | ||
Supplemental disclosures of cash flow information: | ||||||
Income tax paid | ||||||
1,373 | 7 | 1,457 | 2,552 | 390 | ||
Interest paid | ||||||
- | 0 | 0 | 57 | - | ||
Interest received | ||||||
2,984 | 2,733 | 2,377 | 1,703 | 289 | ||
Payable to a related party from repurchase of ordinary shares | ||||||
- | - | - | 0 | - | ||